Pfizer Shares Drop After It Halts Development of Obesity Drug Due to Safety Concerns

Pfizer Shares Drop After It Halts Development of Obesity Drug Due to Safety Concerns

Pfizer Shares Drop As Obesity Drug Halted Over Safety Fears | Time



























Matthew Griffin / Bloomberg

Source link